RE:RE:RE:RE:Biotech buyouts.The Yahoo message board is a "troll factory" run by a hedge fund with the intent of keeping the share price of ONCY low and potential stockholders away.
And these developments may be related to the above:
October 07, 2022 - Replimune secures US$200 Million in a non-dilutive financing loan facility to pursue the anti-PD-1 failed melanoma indication in which AMGEN's IT.OV Imlygic and MSD Keytruda had failed, as announced in early September 2022.
September 15, 2022 - Immuno-oncology company Imugene Ltd. announced an AU$80 million (US$53.9 million) capital raise that will allow the company to add additional studies within its immuno-oncology pipeline as well as pursue potential licensing opportunities.